JD Health and Yunding Xinyao have reached a strategic cooperation to jointly explore a new model for end-to-end services for innovative drugs

Recently, JD Health and the biopharmaceutical company YunDing NewYao signed a strategic cooperation agreement. Both sides will carry out in-depth collaboration in areas including the first release of new innovative drugs, patient services, digital marketing, and internet healthcare, and jointly explore new models to improve access to innovative drugs and manage patients throughout their full care cycle. (JD Health Blackboard News)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned